HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,814,000 | +345.7% | 123,999 | +453.9% | 0.24% | +438.6% |
| Q3 2018 | $407,000 | -82.6% | 22,387 | -81.3% | 0.04% | -77.2% |
| Q1 2018 | $2,343,000 | +23.6% | 119,602 | +9.6% | 0.19% | +7.2% |
| Q3 2017 | $1,895,000 | +57.0% | 109,093 | +15.8% | 0.18% | +63.6% |
| Q2 2017 | $1,207,000 | -21.2% | 94,187 | -39.2% | 0.11% | -41.2% |
| Q4 2016 | $1,531,000 | +230.7% | 154,941 | +188.9% | 0.19% | +222.4% |
| Q2 2016 | $463,000 | – | 53,638 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |